Risk factors
In8bio (INAB) risk factors
Item 1A of every In8bio, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors71 risks4 new11 dropped19 reworded
The company added specific clinical, manufacturing, and regulatory risks regarding its cancer therapies. It also incorporated administrative drug pricing policy uncertainties.
Filed Mar 12, 2026 - FY2024 10-K risk factors78 risks
Substantial doubt about going concern threatens continued operations without significant additional capital raising.
Filed Mar 13, 2025